TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
KURA

Kura Oncology Inc

Healthcare · Biotechnology

10.50$ -1.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 588 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KURA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
76 70 62 56 103 96 141 130 192 182 170 266 255 242 226 353 340 647 620 585 561 534 499 471 448 456 426 495 474 449 554 515 479 760 744 682 649 738 653 588
76 69 61 55 102 95 140 129 190 181 168 264 253 240 221 342 329 637 611 574 549 522 487 460 436 446 416 486 460 432 538 500 463 745 724 660 621 709 624 559
6.8 9.7 11 12 23 11 27 18 21 16 18 122 55 26 34 135 77 325 111 39 39 91 34 39 91 52 27 49 29 37 42 45 49 224 51 82 95 149 39 70
75 68 59 53 101 93 138 126 187 179 166 261 250 237 217 339 325 633 604 567 543 518 480 450 428 438 406 477 453 424 527 492 455 727 658 631 550 667 581 519
0.3 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 – – – – – – – – – – 0.9 – 3.7 – 2.8 – – – 6.1 49 4.6 39 13 14 9.4
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 0.0 – – – 0.4 0.8 2.5
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – 0.6 0.5 0.4 0.3 3.0 8.8 2.1 2.0 2.1 7.7 2.7 2.7 2.6 2.5 2.7 2.5 2.4 5.2 – – – – – – – – – – – –
13 13 12 12 14 16 17 17 17 21 20 19 21 23 23 31 33 36 34 26 27 27 22 22 28 36 31 35 44 52 49 49 55 347 379 377 407 564 545 539
5.3 5.5 4.1 5.1 7.6 10 11 13 13 14 12 11 13 16 15 19 22 26 25 21 22 22 18 18 25 24 19 24 28 35 32 33 40 79 90 107 121 117 101 118
– 7.3 – 0.5 1.0 1.5 2.3 2.8 2.8 – 0.5 – – 0.5 1.0 3.5 4.4 5.1 5.1 2.0 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 1.7 1.5 1.4 2.3 3.4 4.5 3.8 4.8 5.8 1.3 1.3 5.5
0.8 1.4 0.6 0.7 0.7 1.2 2.1 1.8 1.8 3.9 3.4 3.6 2.7 3.5 2.5 0.8 0.8 2.8 1.0 2.4 2.9 3.2 1.3 1.4 1.7 1.5 3.3 2.3 1.8 2.3 7.5 2.1 3.0 1.5 4.6 1.7 4.7 5.0 7.0 2.4
7.3 7.3 7.3 6.9 6.0 5.6 4.9 4.2 3.4 7.5 7.5 7.5 7.5 7.3 6.5 5.8 5.0 4.3 3.5 – – – – – – 9.2 9.2 9.2 9.3 9.3 9.4 8.6 7.8 6.9 7.7 6.5 5.3 9.7 9.7 5.6
64 57 50 44 89 80 125 112 175 161 150 247 234 219 203 322 306 611 586 559 534 507 476 449 420 420 395 460 430 397 505 466 424 414 364 305 243 174 108 48
-47 -54 -61 -69 -79 -89 -104 -119 -134 -150 -164 -179 -195 -213 -232 -253 -276 -303 -333 -367 -400 -433 -465 -500 -536 -569 -603 -640 -679 -721 -771 -822 -876 -895 -953 -1,019 -1,093 -1,174 -1,247 -1,316
19 19 19 20 24 29 32 33 38 38 38 39 45 45 45 52 56 59 66 66 66 67 67 67 67 68 68 70 77 77 84 87 87 87 87 88 88 88 89 89

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?